您的当前位置:首页 > 行业数据 > JS207临床II期研究计划覆盖多个瘤种
图片属性
图片格式:PNG 图片大小:775KB 图片尺寸:1966*919
同报告图片
 / 4
JS207临床II期研究计划覆盖多个瘤种_第1页
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
JS207临床II期研究计划覆盖多个瘤种_第2页
JS207临床II期研究计划覆盖多个瘤种_第3页
JS207临床II期研究计划覆盖多个瘤种_第4页
JS207临床II期研究计划覆盖多个瘤种_第5页
所属报告: 【中邮证券】君实生物(688180)-君实生物:PD-1/VEGF联用方案有望创新引领,国际化正扬帆起航-251023(28页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠